🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To monitor the safety profile and efficacy of GIOTRIF® (afatinib dimaleate,...
Status
Completed
Location
Multiple Locations
Start Date
2014-10-31
Trial ID
NCT02285361
Treatments Being Tested
This study sets out to determine the maximum tolerated dose (MTD) of afatin...
Status
Unknown
Location
Ludwig-Maximilians - University of Munich
Start Date
2016-09
Trial ID
NCT02975141
Treatments Being Tested
This is an open-label, sing-arm, phase IV clinical study. The study is desi...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-06-01
Trial ID
NCT04814056
Treatments Being Tested
This phase II, umbrella trial study directed by next generation sequencing ...
Status
Unknown
Location
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology
Start Date
2018-07-09
Trial ID
NCT03574402
Non-interventional, multi-country, multi-centre cohort study based on exist...
Status
Completed
Location
Royal Marsden Hospital
Start Date
2019-12-17
Trial ID
NCT04179890
Afatinib, a first-in-class irreversible ErbB family blocker, is a 1st line ...
Status
Unknown
Location
Nationa University Hospital
Start Date
2022-10-25
Trial ID
NCT04909073
Treatments Being Tested
To assess if targeting activating EGFR and HER2 mutations in Non-Small Cell...
Status
Completed
Location
Aberdeen Royal Infirmary (NHS Grampian)
Start Date
2016-12-16
Trial ID
NCT02183883
Treatments Being Tested
This is an open-label, sing-arm, single site, phase IV clinical study. The ...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2018-11-27
Trial ID
NCT04132102
Treatments Being Tested